| Literature DB >> 33895212 |
Jiawei Wang1, Yu Zhang1, Niloofar Heshmati Aghda1, Amit Raviraj Pillai1, Rishi Thakkar1, Ali Nokhodchi2, Mohammed Maniruzzaman3.
Abstract
The 'one-size-fits-all' approach followed by conventional drug delivery platforms often restricts its application in pharmaceutical industry, due to the incapability of adapting to individual pharmacokinetic traits. Driven by the development of additive manufacturing (AM) technology, three-dimensional (3D) printed drug delivery medical devices have gained increasing popularity, which offers key advantages over traditional drug delivery systems. The major benefits include the ability to fabricate 3D structures with customizable design and intricate architecture, and most importantly, ease of personalized medication. Furthermore, the emergence of multi-material printing and four-dimensional (4D) printing integrates the benefits of multiple functional materials, and thus provide widespread opportunities for the advancement of personalized drug delivery devices. Despite the remarkable progress made by AM techniques, concerns related to regulatory issues, scalability and cost-effectiveness remain major hurdles. Herein, we provide an overview on the latest accomplishments in 3D printed drug delivery devices as well as major challenges and future perspectives for AM enabled dosage forms and drug delivery systems.Entities:
Keywords: 3D printing; 4D printing; Additive manufacturing; Drug delivery devices; Multi-material 3D printing
Mesh:
Substances:
Year: 2021 PMID: 33895212 DOI: 10.1016/j.addr.2021.04.019
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470